ArticleFrontiers in molecular biosciences2025

Investigating potential targets of Wulingsan in diabetic nephropathy through network pharmacology and experimental validation.

Xicheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.